| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/17/1997 | US5639478 Method to stabilize a pharmaceutical composition and its production |
| 06/17/1997 | US5639473 Subjecting aqueous medium containing biocompatible material capable of being crosslinked by disulfide bonds and nucleic acid construct to high intensity ultrasound waves |
| 06/17/1997 | US5639452 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 06/17/1997 | US5639378 Changing ph by bringing into contact with ionic exchange material |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997020884A1 Process for the preparation of porous polyolefin particles |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020579A2 Novel compounds and use |
| 06/12/1997 | WO1997020571A1 Arctium majus compositions |
| 06/12/1997 | WO1997020569A2 Bioartificial devices and cellular matrices therefor |
| 06/12/1997 | WO1997020563A1 Ligands to enhance cellular uptake of biomolecules |
| 06/12/1997 | WO1997020547A1 Endoparasiticidal agents |
| 06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
| 06/12/1997 | WO1997012581A3 Novel composition containing an acid-labile omeprazole and process for its preparation |
| 06/12/1997 | WO1997012580A3 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2239196A1 Endoparasiticidal agents |
| 06/12/1997 | CA2238379A1 Ligands to enhance cellular uptake of biomolecules |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777679A1 Delivery of nucleic acids |
| 06/11/1997 | EP0777496A1 Topical anti-inflammatory composition and method |
| 06/11/1997 | EP0777495A1 Stable, aqueous alfa interferon solution formulations |
| 06/11/1997 | EP0777487A1 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
| 06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 06/11/1997 | EP0777484A1 Intravenous alendronate formulations |
| 06/11/1997 | EP0777477A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
| 06/11/1997 | EP0777470A1 Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists |
| 06/11/1997 | EP0777467A1 Aerosol drug formulations containing polyglycolyzed glycerides |
| 06/11/1997 | EP0777451A1 Ophthalmic delivery system |
| 06/11/1997 | EP0777415A1 Anandamide analogue compositions and method of treating intraocular hypertention using same |
| 06/11/1997 | EP0654991B1 Inhalation powder containing antistatic agent |
| 06/11/1997 | EP0630234B1 Controlled release acth containing microspheres |
| 06/11/1997 | EP0625034A4 Skin adhesive hydrogel, its preparation and uses. |
| 06/11/1997 | EP0553195B1 Biocompatible microcapsules |
| 06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
| 06/11/1997 | CN1151759A Antibodies which bind to insect jut proteins and their use |
| 06/11/1997 | CN1151398A Prostaglandin E, ester liposome formulations containing them and medicine containing them |
| 06/11/1997 | CN1151323A Accelerating agent of polypeptide medicine mucosa absorbent type |
| 06/11/1997 | CN1151284A Method for prepn. of slowly-released medicaments preparation |
| 06/10/1997 | US5637675 Organometallic copolymeric dyes; redox system |
| 06/10/1997 | US5637620 Micro formoterol particles |
| 06/10/1997 | US5637615 Antiaging agent |
| 06/10/1997 | US5637612 Mixture with dipeptidase inhibitor |
| 06/10/1997 | US5637610 Composition containing dioxabicyclo [3.3.0] octane derivative |
| 06/10/1997 | US5637576 Administering oligosaccharide sequence covalently attached to solid support |
| 06/10/1997 | US5637575 Orally administering liquid composition comprising water soluble sulfated cyclodextrin derivative and nontoxic carrier |
| 06/10/1997 | US5637569 Ganglioside analogs |
| 06/10/1997 | US5637568 Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same |
| 06/10/1997 | US5637564 Hydrophilic part derived from sugar, polyol, aminopolyol; hydrophobic part derived from hydrocarbon, linked to hydrophilic part by junction bearing amino acid |
| 06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 06/10/1997 | US5637460 Restrained multifunctional reagent for surface modification |
| 06/10/1997 | US5637320 Controlled absorption naproxen formulation for once-daily administration |
| 06/10/1997 | US5637318 Increased oxygen penetration of skin |
| 06/10/1997 | US5637313 Matrix of starch hydrolysate and mixture of a water soluble and water insoluble bulking agent |
| 06/10/1997 | US5637293 Stability; discoloration inhibition; mixture of kojic acid, ultraviolet radiation absorber, fatty ester and(or) glyceride |
| 06/10/1997 | US5637289 Carbohydrate microparticles mixed with less water soluble compound |
| 06/10/1997 | US5637288 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 06/10/1997 | CA2106216C Chewable antacid compositions |
| 06/10/1997 | CA2040460C Drug delivery with thermoreversible gels |
| 06/07/1997 | CA2192228A1 Pharmaceutical compositions based on mequitazine |
| 06/05/1997 | WO1997020031A2 Rna polymerase ii carboxyl terminal domain-derived peptides |
| 06/05/1997 | WO1997019996A1 Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide) |
| 06/05/1997 | WO1997019973A1 Novel hydrogels containing triblock copolymers, and preparation and use thereof |
| 06/05/1997 | WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 06/05/1997 | WO1997019954A1 Targeted cytotoxic anthracycline analogs |
| 06/05/1997 | WO1997019922A1 Tetramethylpiperidine-containing copolymers |
| 06/05/1997 | WO1997019703A2 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 06/05/1997 | WO1997019702A2 Powdery iodine complexes |
| 06/05/1997 | WO1997019701A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 06/05/1997 | WO1997019698A1 Diphtheria toxin epitopes |
| 06/05/1997 | WO1997019692A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | WO1997019687A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | WO1997019675A2 Complex cationic lipids |
| 06/05/1997 | WO1997019593A1 Antimicrobial composition and methods of use therefor |
| 06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
| 06/05/1997 | WO1997010810A3 Pharmaceutical granules |
| 06/05/1997 | WO1996039193A3 Drug mitochondrial targeting agents |
| 06/05/1997 | DE19545044A1 Endoparasitizide Mittel Endoparasiticides means |
| 06/05/1997 | DE19544507A1 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/05/1997 | DE19544449A1 Pulverförmige Iod-Komplexe Powdered iodine complexes |
| 06/05/1997 | DE19544404A1 Tetramethylpiperidinhaltige Copolymere Tetramethylpiperidinhaltige copolymers |
| 06/05/1997 | CA2239206A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | CA2239012A1 Diphtheria toxin epitopes |
| 06/05/1997 | CA2238944A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | CA2238484A1 Antimicrobial composition and methods of use therefor |
| 06/04/1997 | EP0776662A1 Pharmaceutical compositions containing mequitazine |
| 06/04/1997 | EP0776660A2 Long-lasting release nifedipine preparation |
| 06/04/1997 | EP0776657A2 Cosmetic and/or pharmaceutical emulsions |
| 06/04/1997 | EP0776656A1 Cosmetic and/or pharmaceutical emulsions |
| 06/04/1997 | EP0776338A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776329A1 Water-soluble polyene conjugate |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776199A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |